Eydelman Mikhail (CIK 0001918033)

Latest company ownership

PCVX - Vaxcyte, Inc.
Role: SVP, GEN COUNSEL & CORP SEC
Shares held
5,000
Last filed at
Mar 7, 2025
Confidence Score
49.3
2025Q4
Confidence Score History
2023Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 5, 2025 Mar 7, 2025 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 22.5 -5,000 -10.73% ✓ $353.7K
Feb 27, 2025 Mar 3, 2025 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 95.0 +13,398 47.47% ✗ $78.7K
Feb 5, 2025 Feb 7, 2025 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 17.5 -5,000 -15.05% ✓ $450.4K
Jan 6, 2025 Jan 7, 2025 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 17.5 -5,000 -15.05% ✓ $427.9K
Dec 5, 2024 Dec 9, 2024 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 35.0 -5,585 -3.66% ✓ $501.2K
Nov 5, 2024 Nov 6, 2024 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 22.5 -5,000 -14.87% ✓ $531.8K
Oct 7, 2024 Oct 8, 2024 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 22.5 -5,000 -14.87% ✓ $546.4K
Oct 1, 2024 Oct 3, 2024 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 17.5 -5,500 -16.12% ✓ $628.3K
Sep 3, 2024 Sep 5, 2024 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 22.5 -3,870 -11.91% ✓ $429.5K
Aug 1, 2024 Aug 5, 2024 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 32.5 -1,667 -5.13% ✓ $131.4K
Jul 1, 2024 Jul 2, 2024 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 32.5 -1,667 -5.13% ✓ $127.3K
Jun 7, 2024 Jun 10, 2024 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 46.3 -335 -1.08% ✗ $23.8K
Jun 3, 2024 Jun 5, 2024 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 32.5 -1,667 -5.08% ✓ $120.1K
May 1, 2024 May 3, 2024 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 32.5 -1,667 -5.17% ✓ $102.9K
Apr 1, 2024 Apr 3, 2024 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 32.5 -1,667 -5.17% ✓ $111.2K
Feb 29, 2024 Mar 4, 2024 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 90.0 +8,220 5.52% ✓ $166.8K
Feb 1, 2024 Feb 5, 2024 Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Sell 32.5 -1,667 -7.45% ✓ $123.1K
Jan 2, 2024 Jan 4, 2024 Vaxcyte, Inc. SVP, Gen Counsel & Corp Sec Sell 32.5 -1,667 -7.45% ✓ $106.6K
Dec 7, 2023 Dec 11, 2023 Vaxcyte, Inc. SVP, Gen Counsel & Corp Sec Sell 7.5 -10,325 -33.27% ✓ $583.5K
Oct 2, 2023 Oct 4, 2023 Vaxcyte, Inc. SVP, Gen Counsel & Corp Sec Sell 5.0 -20,000 -49.40% ✓ $1M
Sep 5, 2023 Sep 6, 2023 Vaxcyte, Inc. SVP, Gen Counsel & Corp Sec Sell 42.5 -1,189 -5.49% ✗ $60.6K
Jun 7, 2023 Jun 9, 2023 Vaxcyte, Inc. SVP, Gen Counsel & Corp Sec Sell 46.3 -645 -2.89% ✗ $33.1K